A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
Article Details
-
Date Published
March 12, 2023
Moreau A, Kervella D, Bouchet-Delbos L, Braudeau C, Saiagh S, Guerif P, Limou S, Moreau A, Bercegeay S, Streitz M, Sawitzki B, James B, Harden PN, Game D, Tang Q, Markmann JF, Roberts ISD, Geissler EK, Dreno B, Josien R, Cuturi MC, Blancho G, consortium D. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients. Kidney Int. 2023 Mar. 103:627-637. doi:10.1016/j.kint.2022.08.037. PMID: 36306921